Pharmaceutical Technology September 22, 2022
GlobalData Thematic Research

With the personalised medicine market reaching $93bn by 2030, there will be a range of treatments available.

It is the year 2030. You have just received the results from your whole genome sequencing test, offered through your public health provider, and discovered that you have a 75% chance of developing a rare form of cancer.

But you are not panicking; your genomic data was automatically uploaded, with your permission, to your electronic health record (EHR), which is fully secured with blockchain technology. Your healthcare practitioner can access the sequencing results, and artificial intelligence (AI) and quantum computing will analyse these records and support the practitioner in making future clinical decisions.

It could be that you...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: 3D Printing, Biotechnology, Pharma, Pharma / Biotech, Robotics/RPA, Technology
Walgreens Suffers $6 Billion Loss As VillageMD Clinic Investment Sours
Covid’s scientific silver lining: A chance to watch the human immune system respond in real time
How GLP-1’s moved from research labs to national TV
Understanding the politics of drug pricing in the United States
Opinion: Oprah kicked off a national conversation on obesity and GLP-1 drugs. Let’s have it

Share This Article